AbbVie and Boehringer Collaborate on Immunology Drugs

09.03.2016 - US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...